5 Recruiting Studies Using Platinum Doublet
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Platinum Doublet
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Non-small Cell Lung Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
📍 Washington University in St. Louis — St Louis, Missouri
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
📍 University of Miami — Miami, Florida
Non Small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Autoimmune Disease
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
📍 Montefiore Einstein Comprehensive Cancer Center (MECCC) — The Bronx, New York
NSCLC
View Study & Checklist ➔